[1]
A. F. KHAN, O. RAICHANDANI, S. RAICHANDANI, and K. PARVEEN, “A STUDY TO EVALUATE THE SAFETY OF ARIPIPRAZOLE IN TREATMENT OF SCHIZOPHRENIA”, Asian J Pharm Clin Res, vol. 14, no. 12, pp. 149–152, Dec. 2021.